Citations

Showing 10 of 108152 citations.

Ultrasonic Percutaneous Tenotomy for Recalcitrant Lateral Elbow Tendinopathy: Clinical and Sonographic Results at 90 Months
Ang, Benjamin F.H., Mohan, P. Chandra, Png, Meng Ai , Howe, Tet Sen , Morrey, B.F. , Morrey, Bernard F, Mohan, P. Chandra, Allen, John Carson , Koh, Joyce Suang Bee , Lee, Brian P.

Mayo Clinic

The American Journal of Sports Medicine | May 9, 2021 | Volume: 49 | Issue: 7 | Pages: 1854-1860

10.1177/03635465211010158 | PMID 33956537 Get It

Background: In a study from our institution, ultrasonic percutaneous tenotomy of the brevis and the common extensor tendon for recalcitrant lateral elbow tendinopathy showed excellent safety profiles, high tolerability, efficiency, sustained pain relief, functional improvement, and sonographic evidence of tissue healing in 20 patients at 3 years’ follow-up. Purpose: To explore the long-term clinical and sonographic results of ultrasonic percutaneous tenotomy of the brevis and the common extensor tendon. Study Design: Case series; Level of evidence, 4. Methods: The same cohort of 20 patients was recalled after 7 years, and visual analog scale (VAS) for pain and Disabilities of the Arm, Shoulder and Hand (DASH) scores, need for secondary intervention, and overall satisfaction were assessed. They were also reassessed using ultrasound imaging of the brevis and the common extensor tendon to evaluate tendon hypervascularity, tendon thickness, and the progress or the recurrence of the hypoechoic scar tissue. Results: We successfully scored 19 patients and performed ultrasound on 16 patients with a median follow-up of 90 months (range, 86-102 months). There were no adverse outcomes and satisfaction remained at 100% (6 patients, satisfied; 13 patients, very satisfied). No patient developed a recurrence of symptoms and signs of lateral elbow tendinopathy, and therefore no secondary intervention was required. The improvement from baseline and early term scores was sustained ( P < .001 for all). At 90 months, there was a significant improvement in VAS scores and DASH–Compulsory scores compared with preprocedure scores and all follow-up times until 3 months. There was no difference in VAS scores and DASH–Compulsory scores at 90 months compared with 6 and 36 months. For DASH–Work scores, there was a significant improvement at 90 months compared with preprocedure scores, but there was no difference between DASH–Work scores at 90 months and scores at all other points of follow-up. At 90 months, hypervascularity remained resolved in 79% of patients, while all patients had reduced tendon swelling and sustained resolution or reduction of the hypoechoic lesion. Conclusion: At the long-term follow-up of 90 months, ultrasonic percutaneous tenotomy of the brevis and the common extensor tendon, previously shown to enhance recovery of lateral elbow tendinopathy, demonstrated good durability of pain relief and functional recovery that was previously achieved. This was accompanied by sustained sonographic tissue healing with no significant deterioration.
Statin Therapy and the Incidence of Thromboembolism and Vascular Events Following Liver Transplantation
Frasco, Peter E. , Aqel, Bashar , Alvord, Jeremy, Poterack, Karl A. , Bauer, Isabel L. , Mathur, Amit K. , Aqel, Bashar A.

Mayo Clinic

Liver Transplantation | May 9, 2021 | Volume: 27 | Issue: 10 | Pages: 1432-1442

10.1002/lt.26093 | PMID 33964102 Get It

Statin therapy may reduce the risk of venous thromboembolism (VTE), which may impact solid organ transplant outcomes. We evaluated the incidence of VTE and other complications after liver transplantation stratified by hyperlipidemia status and statin use using a retrospective cohort study approach. We reviewed all primary orthotopic liver transplantation (OLT) records from January 2014 to December 2019 from our center. Intraoperative deaths were excluded. Recipient, donor clinical and demographic data were collected. We developed risk‐adjusted models to assess the effect of statin use on the occurrence of VTE, hepatic artery complications (HACs), graft failure, and death, accounting for clinical covariates and competing risks. A total of 672 OLT recipients were included in the analysis. Of this cohort, 11.9% (n = 80) received statin therapy. A total of 47 patients (7.0%) had VTE events. HACs occurred in 40 patients (6.0%). A total of 42 (6.1%) patients experienced graft loss, whereas 9.1% (n = 61) of the cohort died during the study interval. Eighty OLT recipients (29.8%) were treated with statins. In the statin treated group, 0% of patients had VTE versus 7.9% of those not on statins (P = 0.02). HACs were identified in 1.2% of the statin group and 6.8% of the nonstatin group. Untreated hyperlipidemia was associated with a 2.1‐fold higher risk of HACs versus patients with no hyperlipidemia status (P = 0.05). Statin therapy was associated with significantly better risk‐adjusted thromboembolic event‐free survival (absence of VTE, cerebrovascular accident, myocardial infarction, HACs, and death); hazard ratio, 2.7; P = 0.01. These data indicate that statin therapy is correlated with a lower rate of VTE and HACs after liver transplantation.
In response to the Letter to the Editor by Hayahito Sakai , Reiko Tsukuura and Takashi Kageyama
Sánchez‐Sotelo, Joaquín , Sanchez-Sotelo, J.

Mayo Clinic

Shoulder & Elbow | May 9, 2021 | Volume: 13 | Issue: 3 | Pages: 347-347

10.1177/17585732211011460 | PMID 34659478 Get It

Obesity Management Education Needs Among General Internists: A Survey
Nanda, S. , Adusumalli, Jayanth , Ghosh, Karthik , Hagenbrock, Martha C., Ratrout, Basem M., Raslau, David , Schroeder, Darrell R. , Wight, Elizabeth C. , Kuhle, Carol L. , Thicke, Lori A., Lazik, Natalia, Croghan, Ivana T. , Hurt, Ryan T. , Ganesh, Ravindra , Croghan, Ivana T , Schroeder, Darrell , Fischer, Karen M.

Mayo Clinic

Journal of Primary Care & Community Health | May 9, 2021 | Volume: 12 | Issue: No issue available | Pages: No page available

10.1177/21501327211013292 | PMID 33949233 Get It

Objective The purpose of this study was to determine self-reported knowledge, attitudes, prior experience, and perceived needs for the management of overweight and obese patients within a General Internal Medicine Practice. Patients and Methods An emailed cross-sectional survey was sent between June 20, 2019 and September 12, 2019 to 194 healthcare workers (93 primary care providers (PCPs) and 101 nurses) which focused on management of patients with weight issues. Results In total, 80 of the eligible 194 participants completed the survey (nurses = 42, PCPs = 38). Up to 87% were white, 74.7% female (74.7%). Most of the responders were either in the age group of 30’s (30%) or 50’s (30%). Among the responders, 48.8% reported some type of specialty training in weight management since their medical training with lectures being the most common form of training (36%). When asked about their interest in either weight management training or strategies to initiate weight conversations, 79% of the respondents reported an interest in education on weight management or strategies to initiate weight conversations, while 65.8% indicated they would be interested in both topics. Conclusion Our study suggests that healthcare workers have a self-reported need for further training in management of overweight and obese patients, irrespective of previous training in this area.
Treatment Approach of Refractory Helicobacter pylori Infection : A Comprehensive Review
Cortés, Pedro , Nelson, Alfred D. , Bi, Yan , Murray, Loren P., Gómez, Victoria , Harris, Dana M. , Stancampiano, Fernando F , Harris, Dana M , Cortés, Pedro , Stancampiano, Fernando F. , Pujalte, George G.A.

Mayo Clinic

Journal of Primary Care & Community Health | May 9, 2021 | Volume: 12 | Issue: No issue available | Pages: No page available

10.1177/21501327211014087 | PMID 33949229 Get It

H. pylori is the most common infection in the world and is associated with gastrointestinal and extra-gastrointestinal manifestations, including peptic ulcer disease, gastrointestinal bleeding, and lymphoproliferative disorders. Despite being discovered less than half a century ago, antibiotic resistance, exacerbated by medication non-adherence and inefficacy of proton pump inhibitors, has grown substantially, explaining the rising incidence of refractory H. pylori infection. In this review, we discuss risk factors, treatment options, surveillance and follow-up, as well as emerging therapies for refractory H. pylori.
Malignancies diagnosed before and after anal squamous cell carcinomas: A SEER registry analysis
Jani, Krupa S. , Lu, Shou‐En , Murphy, James D. , Li, Diana , Chundury, Anupama , Hathout, Lara , Hallemeier, Christopher L. , Li, Diana , Romesser, Paul B. , Jethwa, Krishan R. , Wu, Abraham J , Hathout, Lara , Hallemeier, Christopher Leigh , Jabbour, Salma K

Mayo Clinic

Cancer Medicine | May 8, 2021 | Volume: 10 | Issue: 11 | Pages: 3575-3583

10.1002/cam4.3909 | PMID 33960690 Get It

AbstractBackgroundIncreased risk of a second primary malignancy (SPM) before or after diagnosis of anal squamous cell carcinoma (ASCC) has been reported in a previous single‐institution study. We hypothesize that patients diagnosed with ASCC are at increased risk for developing SPMs before or after the diagnosis of ASCC. The primary objective of this study was to identify the diagnoses of cancer most likely to occur as SPMs before or after ASCC.MethodsThis work employs the Surveillance, Epidemiology, and End Results (SEER) Program registry data to conduct a US‐population‐based study of patients diagnosed with ASCC between 1975 and 2016. In patients diagnosed with ASCC, we evaluated the risk of SPMs and the risk of developing ASCC as an SPM after another cancer using standardized incidence ratios (SIR) for all SPMs by calculating the ratio of observed events in the ASCC cohort compared to expected (O/E) events in a matched reference cohort of the general population.ResultsA total of 7,594 patients with primary ASCC were included. Patients with ASCC were at increased risk of the diagnosis of an SPM (SIR = 1.45), particularly cancers of the lung, vulva, oropharynx, or colon. Patients with ASCC had an increased rate of previous malignancy (SIR = 1.23), especially Kaposi sarcoma or vulvar cancer. Overall elevated incidence of SPMs was unrelated to prior radiation treatment. Radiation treatment was associated with increased risk for SPMs in the female genital system but appeared protective against prostate cancer as SPMs.ConclusionsOur findings support increased surveillance and screening for second malignancies in patients with these diagnoses, as patients with ASCC are often either survivors of a prior cancer diagnosis or are at increased risk of developing later malignancies.
Impact of R-CHOP dose intensity on survival outcomes in diffuse large B-cell lymphoma: a systematic review
Bataillard, Edward , Cheah, Chan Y. , Maurer, Matthew J. , Khurana, Arushi , Eyre, Toby A. , El‐Galaly, Tarec Christoffer , Bataillard, Edward J , Cheah, Chan Yoon , Maurer, Matthew , El-Galaly, Tarec C

Mayo Clinic

Blood Advances | May 8, 2021 | Volume: 5 | Issue: 9 | Pages: 2426-2437

10.1182/bloodadvances.2021004665 | PMID 33961018 Get It

Abstract The dilemma of whether to treat elderly patients with diffuse large B-cell lymphoma (DLBCL) with a full or reduced dose intensity (DI) of R-CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisolone+rituximab) is often faced by clinicians. We conducted a systematic review assessing the impact of R-CHOP DI on DLBCL survival outcomes, according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Protocols (PRISMA-P) guidelines. We searched MEDLINE, EMBASE, and Cochrane CENTRAL for studies with ≥100 patients treated with R-CHOP/R-CHOP–like therapies published from January 2002 through November 2020. Studies were included if they reported the impact of R-CHOP DI on survival outcomes. We screened records, extracted data, and reviewed all the studies for quality and statistical appraisal. Of 380 screened records, 13 studies including 5188 patients were reviewed. DI was often calculated as the ratio of the cumulative delivered dose of prespecified drug(s) to the cumulative planned dose multiplied by a time-correction factor. Lower DI (intended or relative) was associated with inferior survival in 7 of 9 studies reporting crude survival analyses. Multivariable analysis using DI as a covariate was performed in 10 studies. Six showed an association (P &lt; .05) with adjustment for other covariates, and 4 did not. Most studies and those larger studies of higher quality showed poorer outcomes associated with reduced DI. In subgroups aged ≥80 years, survival was not consistently affected by reduced DI. DI-specific randomized trials are warranted, but these data support full-dose R-CHOP in elderly and fit patients aged &lt;80 years with DLBCL, but not in those aged ≥80 years, where dose-reduced R-CHOP does not appear to compromise survival.
Auditory Attention following a Left Hemisphere Stroke: Comparisons of Alerting, Orienting, and Executive Control Performance Using an Auditory Attention Network Test
LaCroix, Arianna N. , Rogalsky, Corianne , Baxter, Leslie C.

Mayo Clinic

Auditory Perception & Cognition | May 8, 2021 | Volume: 3 | Issue: 4 | Pages: 238-251

10.1080/25742442.2021.1922988 | PMID 34671722 Get It

Survey of the Transcription Factor Responses of Mouse Lung Alveolar Macrophages to Pneumocystis murina
Kottom, Theodore J. , Schaefbauer, Kyle, Carmona, Eva M. , Carmona, Eva M , Kottom, Theodore J , Limper, Andrew H.

Mayo Clinic

Pathogens | May 8, 2021 | Volume: 10 | Issue: 5 | Pages: 569

10.3390/pathogens10050569 | PMID 34066663 Get It

Pneumocystis jirovecii is a fungal pathogen that can cause life-threatening infections in individuals who are immunocompromised. Acquired via inhalation, upon entering the respiratory tract, the fungi first encounter innate immune cells such as alveolar macrophages (AMs). Relatively little is known about the AM cellular responses to the organism, and particularly transcription factor (TF) profiles leading to early host responses during infection. Utilizing the Mouse Transcription Factors RT2 Profiler™ PCR Array, we report an initial TF survey of these macrophage and Pneumocystis interactions. Expression levels of a panel of mouse TFs were compared between unstimulated and Pneumocystis murina-stimulated AMs. Interestingly, a number of TFs previously implicated in pathogen–host cell interactions were highly up- or downregulated, including hif1a and Pparg. qPCR experiments were further conducted to verify the results of these surveyed transcripts. Furthermore, with immunoblotting, we show that HIF-1A and PPAR-γ are indeed significantly upregulated and downregulated, respectively. Lastly, and importantly, we report that in the mouse model of Pneumocystis pneumonia (PCP), which mimics human Pneumocystis jirovecii pneumonia (PJP), qPCR analysis of Pneumocystis murina lungs also mimic the initial TF profile analysis, suggesting an importance for these TFs in immunocompromised hosts with Pneumocystis pneumonia. These data demonstrate the use of TF profiling in host AMs and Pneumocystis organism interactions that may lead to a better understanding of the specific inflammatory responses of the host to Pneumocystis pneumonia and may inform novel strategies for potential therapeutics.